Skip to main content

Table 5 Diagnostic test characteristics for moderate and severe cervical lesions

From: Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol

 

CIN2+

CIN3

Sensitivity

90.8%(84.7–95.0%)

92.3%(84.8–96.9%)

Specificity

42.6%(38.5–46.9%)

40.0%(36.1–44.0%)

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us